Six Red-hot IoT Predictions for 2018

By Matt Smith, CTO at Software AG.

Read More
2018 IoT Predictions

By Mike Bell, EVP Devices & IoT, Canonical.

Read More
Cybersecurity Predictions for 2018

NordVPN offers predictions and advice for 2018.

Read More
Clarifying digital transformation – before it’s too late

With DX beginning to suffer from the same over hyping that has beset far too many IT industry...

Read More
GDPR and Machine Learning to be dominating topics

As 2017 comes to an end, the impending implementation of GDPR looms and the rise of automation...

Read More
GDPR: protect your data, recover more quickly.

By David Trossell, CEO and CTO of Bridgeworks.

Read More
NEWS
To buy or to build? That is the question

By Mark Baker, Field Product Manager, Canonical.

Read More
HPC and OpenStack – where does it fit in?

By Andrew Dean, HPC Business Development Manager at HPC, Storage and Data Analytics Integrator, OCF.

Read More

Videos

Neil Fowler, SVP of Hybrid Cloud Engineering at Rocket Software, discusses the challenges and opportunities of IT modernisation, offering some valuable insights as to the essential ingredients of a successful...
Mat Brown, Senior Technical Marketing Engineer | Sustainability: Data Center & Hybrid Multicloud at Nutanix, who worked closely with Atlantic Ventures, as they produced the ‘Improving Sustainability in Data...
News and views from the recent DCA-organised Data Centre Transformation (DCT) 24 event.
News and views from the recent DCA-organised Data Centre Transformation 2024 event.

News

Channel partners can now use customised AI assistants, powered by ArrowSphere AI, to reinvent the way they manage business operations and engage with their customers.
NTT DATA research shows organizations shifting from experiments to investments that drive performance.
Skillsoft has released its 2024 IT Skills and Salary Report. Based on insights from more than 5,100 global IT decision-makers and professionals, the annual report examines the state of the IT industry and...
The promise of AI is on every biopharma’s radar, but the reality today is that much of the industry is grappling with how to convert the hype into impact.